⌘K

Login Start Free

Home/Filings/4/0001209191-21-008638

4//SEC Filing

Kwan Pui San 4

Accession 0001209191-21-008638

CIK 0001340652other

View on SEC.gov Company Profile

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 8:25 PM ET

Size

16.0 KB

Accession

0001209191-21-008638

Insider Transaction Report

Form 4

Period: 2021-02-04

ChemoCentryx, Inc.CCXI

Principal Acctg Officer

Transactions

Exercise/Conversion
Common Stock
2021-02-04$10.86/sh+1,389$15,085→ 4,621 total
Sale
Common Stock
2021-02-04$65.00/sh−3,347$217,555→ 3,232 total
Exercise/Conversion
Stock Option (right to buy)
2021-02-04−1,389→ 15,286 total
Exercise: $10.86Exp: 2028-03-05→ Common Stock (1,389 underlying)
Exercise/Conversion
Stock Option (right to buy)
2021-02-04−833→ 26,667 total
Exercise: $9.04Exp: 2029-11-01→ Common Stock (833 underlying)
Exercise/Conversion
Common Stock
2021-02-04$11.02/sh+1,125$12,398→ 5,746 total
Exercise/Conversion
Common Stock
2021-02-04$9.04/sh+833$7,530→ 6,579 total
Exercise/Conversion
Stock Option (right to buy)
2021-02-04−1,125→ 25,875 total
Exercise: $11.02Exp: 2029-03-04→ Common Stock (1,125 underlying)

Footnotes (3)

[F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
[F2]As of February 4, 2021, and prior to this transaction, the exercised options were fully vested.
[F3]Not applicable.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ChemoCentryx, Inc.

CIK 0001340652

Entity typeother

Related Parties

1

filerCIK 0001733642

Filing Metadata

Form type: 4
Filed: Feb 7, 7:00 PM ET
Accepted: Feb 8, 8:25 PM ET
Size: 16.0 KB

View on SEC.gov